MaxGXL Testimonials On Various Health Conditions

Here are a selection of testimonials about MaxGXL and how it has changed people’s lives. Don’t take our word for it – check out what athletes, doctors, distributors and everyday people are saying!
Everyday People   (Please find link to buy MaxGXL at the end of this post below)

Shawn King
Wife of CNN Talk Show Host Larry King

“Everything I’d love to say about MaxGXL, they tell me I can’t say because we’re not supposed to talk about the unbelievable things we’ve seen. Keeping up with Larry’s schedule in itself can be exhausting. Add to that my responsibilities as a full-time mom to our two boys, working on my own show and singing career, and there aren’t enough hours in the day to get everything done, stress-free. Max has changed everything. You just feel good all day. So when my kids want to have some quality time. I’m there for them 100 percent. I can go without a lot of things in life, but MaxGXL isn’t one of them.”

Charlene Ragsdale
Las Vegas, Nevada

“I had a series of health issues beginning in the late 1980’s. In 2001, I had a complete hysterectomy that helped my body to function better but I also developed some horrible side effects—especially a lack of sleep. After 4 days of being on MaxGXL, I slept through an entire night! In addition, when I would get up, I limped from a sports injury in my left knee. One morning after a week of being on MaxGXL, my son said, ‘Momma—you are not limping! What happened?’ My limp went away! I can now live my life to the Max!”

Debby Pruitt
Houston, Texas

“I’ve struggled with weight loss issues all my life. A friend introduced me to MaxGXL. I got on the product and had no idea, but major changes happened to me physically. I began to do things that I hadn’t been able to do in a long, long time without discomfort. The next thing I knew, the new product, MaxWLX, was introduced to me. The first month or so that I was on the product, I saw a little bit of change in inches. The next month, I’m like WOW! Pretty amazing! Clothes that I was wearing were beginning to get loose. I’m just excited to know that there’s a new me inside here.”

Pamala Wilson
Redding, California

“This is the easiest, most remarkable program I’ve ever experienced! In less than eight weeks, I lost 13 pounds of body fat. But the big thing for me is size and I lost two dress sizes—absolutely remarkable! I think the most important feeling I’m having right now is, I like myself, I literally like myself. This has been a blessing!”

Dan Worley
Charlotte, North Carolina

“A few years ago, my dad had a quadruple bypass at the age of 48 when I was in my late twenties. I was working corporate America and I didn’t have time to exercise and go to the gym like I wanted to. So I started to put on some weight and my cholesterol level was 275 to 300. I knew that if I didn’t change some things, I was going to be in the same situation as my dad. A couple of months ago, a friend of mine introduced me to MaxWLX and in the first month I lost 30 pounds and my waist size went from a 33 to a 29. My cholesterol level dropped from 275 to below 200.”

Claudia Airola
Los Angeles, California

“I have felt great every day! GXL could be the secret to protecting us from viruses our body is not immune to. I have my parents and my Grandma on it because the government has already released a statement that they will not treat anyone over the age of 50 (or under the age of 2) for the Avian Flu when it reaches the US. They will need to fight this off themselves. Health of our families is the most valuable (earthly) thing we have. This really is incredible.”
Athletes

Wayne Lloy
Retired, 65 Years Old

“My training and energy went thought the roof. For the first time in my life I was able to train twice a day with equal intensity, my recovery times were considerable shorter and I actually trained 7 days a week. My knee problem which prevented me from running was gone I was now running intervals with 8 minute miles. I have not run in over 20 years and had surgery on one knee. A problem I had called white hand… woke me up every night to get the blood flow back to my hands was gone.”
Ernest Chang
Police Officer & Bodybuilder

“Within three to four days, I felt a difference. I had a sustained energy level. I sleep better at night and need less sleep then before I started taking Max. My training-recuperation ability increased greatly. Not only did I recover faster from each workout, I also recovered faster between sets. The best way I can describe it is like my lungs felt supercharged. Other huge differences were my increased strength and my number of repetitions.”
Herb Gee
Herb Gee
Runner

“In October 2007, I was scheduled to participate in five events at the Huntsman World Senior Games, in St. George, Utah. I just didn’t have the explosive power anymore, but I decided to go because of what I’d already invested.” After winning several races throughout the day, the 66 year old was fatigued, then the time came for his last event, the 100-meter run – his specialty. “The gun went off, I rocketed out of the starting blocks and led from start to finish, winning, I am told by spectators, by about a meter…a race typically won by inches. There is no doubt in my mind that MaxGXL was my partner in the gold.”
Tom Jones
Tom Jones
Two-time World Champion Kickboxer & Runner

A 44-year-old extreme endurance athlete, Tom Jones knows the power of a quick recovery and routinely pushes his body past what many would consider normal physical limits. “Shortly after I started taking MaxGXL I started experiencing overall increased energy, quicker recovery time after training 5 to 7 hours a day and -most importantly for me- I have experienced little to no swelling in my hips, knees, back, elbows and shoulders after training sessions. I can now see myself being an extreme endurance athlete for years to come, thanks to MaxGXL.”
Kevin Saunders
Kevin Saunders
Wheelchair Athlete

Kevin Saunders has achieved athletic distinction, earning titles such as World’s Greatest Wheelchair Athlete, by serving as a member of the President’s Council on Physical Fitness and Sports and as International Ambassador on Health & Fitness. But he says MaxGXL helped him fine-tune his athletic performance. “MaxGXL is an amazing tool for any athlete looking to go to the next level,” he says. “As a world champion athlete, I thought I’d tried everything, but I’ve been blown away. Instead of having down days and feeling tired, I’ve found that MaxGXL gives me the boost to power through.”
Ian Walling
Ian Walling
Bodybuilder

Ian Walling is a professional athlete with many titles under his belt: WNSO World Pro Champion, Mr. Natural Universe 1998, Natural Olympia gold medal winner and several others. He’s also a personal trainer to future natural bodybuilders. “Since I have been using MaxGXL, I just feel better,” he says. “My energy is great. I noticed that my muscle recovery has increased after my workouts. I take MaxGXL before AND after I work out.”
St. George Roadrunners
St. George Roadrunners
Minor League Baseball Team

The St. George Roadrunners, a minor league baseball team in St. George, Utah, have used MaxGXL since 2007. The team as a whole has noticed a difference in their performance and recovery times since starting MaxGXL. Team Member Ryan Stephenson notes, “we play games almost every day, and my recovery time is awesome,” he says, “I wake-up feeling refreshed and ready to go.” Teammate Steven Wright shares a similar view. “Once I started using MaxGXL, I noticed a change in my body’s recovery,” he says. “My body has responded with great, fast and intense recovery, which enhances my performance.”
Corey Snyder
Corey Snyder
Manager of the St. George Roadrunners

Corey Snyder, the St. George Roadrunners’ manager, could detect the difference MaxGXL made in his life. After pitching and hitting balls all day during tryouts, he expected to be sore the next day… but he wasn’t. That’s when he decided to share MaxGXL with his team, who absolutely loved it. “The pitchers recover quicker from their outings,” he says. “And I can throw batting practice every day and feel no discomfort or stress on my arm.”
Jonathan Miller
Jonathan Miller
Competitive Swimmer

“MaxGXL is a product that I’m very happy to be part of. Not only have I been breaking records in swimming, but I’ve also noticed an amazing level of energy through-out my day. Growing up I always wanted to do something about aging, which is why I compete as a master athlete now. The plan is to swim as long as I can, and hopefully keep looking this good.”
Doctors
Dr. Corinne Allen
Dr. Corinne Allen
MD, Researcher in Natural Health, Nutrition, and Brain Disabilities – Idaho

“As soon as I heard about MaxGXL, I knew it was important. It has been the most significant product that I have ever used for the nutritional support of the brain and nervous system. I have never seen such fast, amazing and life-changing results from a single nutritional supplement. I work with all levels of brain injuries, mild to severe, and I find that from babies on up, if they have brain, emotional or developmental issues, they are severely lacking in glutathione.” Speaking of her personal experience with MaxGXL, Dr. Allen said, “My energy level has doubled. I find that I have more sustained energy for 12 to 15 hours a day.”
Dr. Daria Davidson
Dr. Daria Davidson
MD, RN, Board Certified in Emergency Medicine and Holistic Medicine – Bellevue, Washington

“This is probably the most significant nutritional product I’ll ever see in my lifetime. The results from the many people who have experienced MaxGXL are nothing short of incredible.” With 13 years of experience in the marketing industry, Dr. Davidson sees Max in a league of its own. “Max represents a business opportunity that all Associates can feel confident in representing. We all get to live with the rewards and the consequences of our decisions. Taking action with Max International on the product and business side will be the “reward” for so many people. It is a privilege to be part of something this big.”
Dr. Charles Mabray
Dr. Charles Mabray
MD, OB/GYN, Diplomat of the American Board of Environmental Medicine, ABBM Certified- Texas

Introduced to Max in May 2007, he began to offer MaxGXL on a small scale to patients, family and friends. “It rapidly became obvious that MaxGXL had something special, yielding quality of life improvement in multiple areas. I am now a full-fledged fan.” As for Max WLX, Dr. Mabray said he is seeing some great results. “I encourage the medical board to devise clinical studies that we can share and perform in our practices to document the power of our product to safely change lives. I am honored to serve in this capacity and will do my best to uphold the quality and integrity of our founders and leaders.”
Dr. John Kindle
Dr. John Kindle
MD – Family Practitioner, Chief of the Childhood Care Division at his Hospital – Ontario, CA

“It’s so rewarding when people come in and say, ‘I want more – I’m afraid I’ll run out.’ And they’ll say, ‘I gave some to my mom and she’s got energy and swears by this stuff now! She’s telling all her friends and neighbors about it.’ That’s the kind of thing that gives me the belief.” Dr. Kindle praised Dr. Keller for developing a one-of-a-kind, patented product that has actually been shown to produce glutathione in the body. Dr. Kindle said there may be glutathione products out there, but nothing with the state-of-the-art science of MaxGXL.
Dr. Tim Kershenstein
Dr. Tim Kershenstein
MD – Family Practitioner, Chief of the Childhood Care Division at his Hospital – Ontario, CA

“In my opinion the West is too quick to revert to pharmaceutical drugs for treatment, when the use of a natural remedy would be more appropriate and with few side effects.” Dr. Kershenstein said 80 percent of people he’s presented MaxGXL to have responded quickly with definite results. “It will take time for Western physicians to embrace this great product. I firmly believe that MaxGXL will change the medical community’s thinking – that it is a positive approach using of MaxGXL in their practice.”

MaxGXL Testimonials
Real People, Real Stories

Amazing endurance and muscle recovery. This product has been truly amazing in my training for my 10th marathon. I can run 18 miles and the following day I truly have no muscle fatigue or soreness. The elevated levels of naturally produced glutathione in my body have given me more energy, more intense abilities to workout, and it’s given me the amazing ability to see my body as it should be with mental focus and overall clarity. I love this stuff. I will use it for the rest of my life as will many others in my family. I recommend it for the folks who are extreme athletes to those that are loaded with minor aches and pains. Because it effects the bodies natural antioxidant, glutathione, it is able to respond to many different needs of various people ranging from minor aches and pains to major illness such as cancer and HIV. It’s not a cure or intended to treat any diseases, yet because it’s working for body so many other things are being eliminated for folks. -Nate B.

Relief from fatigue and discomfort

My name is Allison Fleming. I am 50 years old, married, mother of two boys and a first grade teacher. I’ve had some serious fatigue issues and on June 5, 2007 I had hip replacement surgery. Something went wrong during surgery and after 8 months on a walker and many more months using a cane I finally began to be able to walk on my own. I have never stopped living in discomfort. I was able to continue working, but by the time I got home each day all I wanted to do was sit. It was so difficult to get out of my chair just to walk across the room that I usually stayed there most of the day. When I did get up I could only shuffle-walk down the hall. I didn’t want to do housework, cook, or go anywhere at night. About the only time I went out at night was to go to church. I was constantly praying and asking God for help. I began swimming a mile a day because being in the water was the only place I could be and not hurt.

In November of 2008, the mother of one of my students brought me a small red box of MaxGXL. She asked me to try it for one week. I took the product for 3 days and thought I was feeling better, but got a virus and stopped taking it. A couple of days later I began taking it again. I thought I didn’t seem to have as much discomfort. So I got another box of MaxGXL and took it another week. I couldn’t believe how much better I was feeling. I have been on MaxGXL for three months now and it is unbelievable how I feel! I have my life back.

I have been going out at night, shopping, and walking without discomfort. This Christmas we went to the mountains with my son who had just returned from Iraq. I was able to go bowling, play putt putt golf, and went to Dollywood. I am also going on a ten-day mission trip to Odessa Ukraine in July. If not for MaxGXL this would not have been possible.

I have recently begun taking Max WLX and lost 8 pounds in 16 days. I have been trying to lose weight for a long time and I know that this is the answer to my problem. I can’t wait to see what this has done for me in 6 months.

I know if I had not been introduced to MaxGXL I would still be sitting in my chair and wondering what kind of future was ahead of me. I am walking proof that MaxGXL gave me my life back and I will do my best to let everyone know what an awesome product MaxGXL is and how it can change your life.

Allison L. Fleming

Increased strength and better sleep

As a police officer for 10 years, Ernest Chang maintains a fit and active body. But fitness is also a personal interest: He competes in bodybuilding contests regularly and trains extensively. He began taking MaxGXL at his manager’s suggestion while training for the National Physique Committee’s Paradise Cup Bodybuilding and Figure Championships in 2007. “Within three to four days, I felt a difference,” he says. “I had a sustained energy level. I sleep better at night and need less sleep then before I started taking Max. My training-recuperation ability increased greatly. Not only did I recover faster from each workout, I also recovered faster between sets. The best way I can describe it is like my lungs felt supercharged. Other huge differences were my increased strength and my number of repetitions.”

Mike Perason’s Marathons and Triathlons

Mike Pearson is a 46-year old who decided to run his first marathon in December 2007. He trainded for the Honolulu Marathon late and was astonished to find there was no discomfort and no sore muscles in his first weeks of rigorous training because he had been talking MaxGXL. Michael maintained the training schedule that kept him on track and completed the race.

Bolstered bu his successful first marathon, Michael also participated in the Honolulu Triathalon in May 2008, which consists of a 1,500 meter swim, a 25-mile bike ride and a10km run. He continued to feel good after tat race so he entered the Hawaii Tin Man, another triathlon, in July. “I’ve never done any type of even like this in my life,” Michael says. “But because Max allowed me to train without the discomfort normally associated with that much physical strain I will now look for other challenges.

Dr. Charles Mabray
Max GXL Testimanial

Dr. Charles Mabray said his interest in MaxGXL was immediately roused when a friend told him he had a product that helped the body manufacture and use glutathione. He was reassured when he discovered the ingredients were safe, natural substances.
He started using it himself and got several members of his staff and his wife to try the product.

The responses from these test subjects went well beyond his expectations. They expressed improvement in sleep, relief from discomforts and jumpy legs, to name just a few. With his initial success with the product Dr. Mabray branched out and started introducing select patients and friends to MaxGXL and the results continue to exceed his expectations. “In all my 35 plus years of practice, I have never seen a supplement or medication that helps so many, so much, so quickly,” he said.

Shawn King, wife of Larry King, started using MaxGXL to keep up with her husband’s crazy schedule and lifestyle

Shawn King about MaxGXL, in her own words:

Keeping up with Larry’s schedule in itself can be exhausting. Add to that my responsibilities as a full-time mom to our two boys, working on my own television show and singing career, and there aren’t enough hours in the day to get everything done, stress-free.

Until I started using Max, my energy level would fall off sharply just after lunch. I’d find myself dying for a nap, but never having even a moment to take one. By the time Larry would get home from his show, I was usually worn to a frazzle. But our days never stop with dinner. Whether it’s a movie screening or a charity event, our evenings are filled with activities, as well.

Max has changed everything. From the time I wake up (early enough to get the kids to school) until the time my head hits the pillow, I’ve got all the energy I need. And it’s not like the buzz you get from caffeine drinks. You just feel good all day. I feel just as energetic at 2 in the afternoon as I feel at 7:30 in the morning . . . I’ve also noticed that my mental focus is incredibly strong throughout the day. So when my kids want to have some quality time, I’m there for them 100%. I’ve also been amazed that I’m not as sore from exercise, and I recover from workouts a lot faster.

“I started MAXGXL in July 2007, not looking for a major result but taking the product for it’s preventative benefits with cancer. Three weeks later my sore ribs that I had from breaking them four years earlier were without pain. Afternoon nods went away, and sleep was deeper than it had been in years. All within the first month! Since it can take up to six months to fully build up your glutathione, I am looking forward to the next few months of improved health.” -Bob McDonald

“I have been living with day to day pain for the past 37 years from osteoarthritis. Though I have it in my joints it is mainly in my neck causing stiffness of the muscles and joints. The resulting pain and decreased flexibility make it difficult to function well doing daily activities and working.

I have tried many types of medical and natural remedies with some degree of relief. The natural ones worked best with the fewest side-effects and lasted longer than other remedies per dose. I am always looking for something that will make life easier for me and others who suffer from any pain.

I was introduced to MaxGXL at the end of June 2007. I was very skeptical, as I am sure most are, but decided to try it for 2 months. I’m glad I did as I didn’t notice any difference in the first 2 weeks but had increased energy and less muscle stiffness by the end of the first month.

Two months later I am delighted to say driving is no longer a ‘pain in the neck’. I can now shoulder check without that annoying stab of pain. Working at the computer or on the phone does not result in downtime to recuperate and playing with my grandchildren is a while lot more fun.

Even my Chiropractor has noticed that I have more flexion and less muscle knots. The treatments are holding for a longer time so I don’t need to return to her office as often giving me more time to tell others about MaxGXL.” – Margery

article reposted from https://davidbrunt.wordpress.com/maxgxl-testimonials/

To buy as a Preferred Customer if you are from Australia,

 Cameroon, Canada, Colombia, Costa Rica, Dominican Republic,

 Ecuador, El Salvador, Fiji, Ghana, Guatemala, HongKong, 

Ivory Coast, Kenya, Malaysia, Mexico, New Zealand, Nigeria,

 Philippines, Singapore and United States... 

please click on BUY NOW 

Christine Dauz

Max™ Sales Associate.. trusted Max Online Seller

paperworksgalore@gmail.com

👉🏻09513506589 call/whatsapp

👉🏻63906-6151422

Courier:

� Local (LBC/J&T ) 1-2days

� International ( EMS Philpost )

Arrival : 3-5 Working days

Payments accepted: GCASH, Remitly, WorldRemit, Moneygram, BDO Deposit/BPI Deposit

 

Herbal Remedy For Gallstones

REMOVING GALLSTONES NATURALLY...

By: Dr. Lai Chiu Nan

It has worked for many. If it works for you please pass on the good news. Dr. Lai is not charging for it, so we should make it free for everyone. Your reward is when someone, through your word of mouth, benefits from the regime. Gallstones may not be everyone's concern. But they should be because we all have them. Moreover, gallstones may lead to cancer. "Cancer is never the first illness," Dr. Lai points out. "Usually, there are a lot of other problems leading to cancer.

In my research in China , I came across some materials which say that people with cancer usually have stones. We all have gallstones. It's a matter of big or small, many or few.

One of the symptoms of gallstones is a feeling of bloatedness after a heavy meal. You feel like you can't digest the food. If it gets more serious, you feel pain in the liver area." So if you think you have gallstones, Dr. Lai offers the following method to remove them naturally.

The treatment is also good for those with a weak liver, because the liver and gallbladder are closely linked.

Regimen:

1. For the first five days, take four glasses of apple juice every day. Or eat four or five apples, whichever you prefer. Apple juice softens the gallstones. During the five days, eat normally.

2. On the sixth day, take no dinner.

3. At 6 PM, take a teaspoon of Epsom salt (magnesium sulphate) with a glass of warm water.

4. At 8 PM, repeat the same. Magnesium sulphate opens the gallbladder ducts.

5. At 10 PM, take half cup olive oil (or sesame oil) with half cup fresh lemon juice. Mix it well and drink it. The oil lubricates the stones to ease their passage.

The next morning, you will find green stones in your stools. "Usually they float," Chiu Nan notes. "You might want to count them. I have had people who passes 40, 50 or up to 100 stones. Very many."

"Even if you don't have any symptom s of gallstones, you still might have some. It's always good to give your gall bladder a clean-up now and then.

PASS THIS AND YOU MAY HELP OTHERS!
Share your knowledge. Its a way to achieve immortality.

I personally used this process above and after that taking MaxGXL helped me greatly to dissolve the gallstones completely. If I can find the video of my testimony, I will post here too

To buy as a Preferred Customer if you are from Australia,

 Cameroon, Canada, Colombia, Costa Rica, Dominican Republic,

 Ecuador, El Salvador, Fiji, Ghana, Guatemala, HongKong, 

Ivory Coast, Kenya, Malaysia, Mexico, New Zealand, Nigeria,

 Philippines, Singapore and United States... 

please click on BUY NOW below 

https://www.mymaxoffice.com/775366

maxgxl reviews

is maalox good for gallstones

gallstones k80.20

large gallstone removal

magnesium malate gallstones

maalox for gallbladder pain

nac gallstones

nac gallbladder

buy cellgevity, buy cellgevity online, buy maxgxl ,cellgevity, cellgevity benefits, 

cellgevity side effects , cellgevity testimonials, 

market america, max gxl review philippines,  max international, 

max international australia, max international business, max international canada,

max international cellgevity, fkc international, advocare, agel, max gxl dietary supplement price, 

max gxl dosage, max gxl food supplement, max gxl for sale, max gxl for sale philippines,

max gxl glutathione benefits, max gxl glutathione price, max gxl glutathione reviews,  cellgevity cost,  

cellgevity dietary supplement, cellgevity price, global max international,  

gxl 10 pill,     

gxl 5 pill, gxl food supplement,  antioxidants, health benefits of maxgxl,  does maxgxl really work,  

dr keller maxgxl, dr. keller maxgxl died, dx max international,max cellgevity reviews, max cellgevity side effects, max cellgevity testimonials,

max dietary supplement, max food supplement, max gel food supplement, max gluta, max gsl,  

max gxl,max gxl 3, max gxl australia, max gxl benefits, max gxl dietary supplement,   

max gxl glutathione side effects, max gxl glutathione uk, max gxl international, max gxl nagasawa,max gxl oxl, max gxl philippines, max gxl price, max gxl review,max international inc, max international, max international llc, max international login, max international logo, max international ltd, 

 max international cellgevity side effects, max international company, max international dubai,

max international malaysia, max international nz, max international philippines, 

max international utah,  , max supplements reviews, max xl supplement,

maxgxl, maxgxl 2015, max one supplement reviews, max one supplement side effects, limu company,

  max international reviews, max international scam, max international singapore, max international uk, max international product reviews, max international products, maxgxl 400,  maxgxl amazon, maxgxl and breast cancer, maxgxl and cancer, maxgxl and diabetes, maxgxl and pregnancy, maxgxl and rheumatoid arthritis, maxgxl associate login, maxgxl australia, maxgxl australia buy, maxgxl australia-scam,    

maxgxl autoship, maxgxl back office, maxgxl before and after, maxgxl benefits, maxgxl best price,  

maxgxl bfad, maxgxl blog, maxgxl box, maxgxl brochure, maxgxl business opportunity,    

maxgxl buy, maxgxl canada, maxgxl cancer cure, maxgxl capsule, maxgxl cebu,  

maxgxl cellgevity, maxgxl clinical study, maxgxl complaints, maxgxl contact number 09513506589,   

maxgxl contents, maxgxl dangers, maxgxl detox symptoms,  maxgxl diabetes testimonial, maxgxl dietary supplement, maxgxl dietary supplement benefits, maxgxl dietary supplement dosage,    

maxgxl dietary supplement philippines, maxgxl dietary supplement price,   

maxgxl dietary supplement reviews, maxgxl dietary supplement side effects,  

maxgxl distributor, maxgxl dosage, maxgxl dubai, maxgxl ebay, maxgxl effects,   

maxgxl en chile, maxgxl en espanol,maxgxl facebook, maxgxl fda approved, maxgxl female network, 

maxgxl for cancer, maxgxl for kidney, maxgxl for pcos, maxgxl for pregnant, maxgxl for weight loss,  

maxgxl glutathione, maxgxl glutathione accelerator, maxgxl glutathione accelerator side effects, maxgxl glutathione accelerator skin whitening, maxgxl glutathione australia, maxgxl glutathione en español ,maxgxl hair growth, maxgxl health benefits, maxgxl health products, maxgxl herbal, maxgxl history, maxgxl hiv, 

maxgxl hk, maxgxl hong kong,maxgxl how to take,  maxgxl image, maxgxl in dubai, maxgxl in india, maxgxl in uae, maxgxl ingredients, maxgxl ingredients list, maxgxl intake,  maxgxl international, maxgxl international login, maxgxl international philippines,maxgxl istorya, maxgxl kidney failure  

Max International - Dr. Keller, Formulator of MaxGXL™

Robert Keller, MD, MS, FACP, has been named as one of the world’s 2,000 Outstanding Scientists of the 21st Century, and has served on the scientific review panels for the National Institutes of Health and the VA.

Dr. Keller has served on the faculties of the Mayo Graduate School of Medicine, the University of Wisconsin and the Medical College of Wisconsin (Marquette Univ.) He has published more than 100 original articles in various scientific and medical journals and has been awarded several patents. Dr Keller was elected to The Board of Governors of the American Academy of HIV medicine, and serves on the Scientific Advisory Board of several Biotech companies. The Consumers’ Research Council has named Dr. Keller one of America’s “Top Physicians in 2003, 2004 and 2005 in the fields of Internal Medicine, Immunology and Hematology. Dr. Keller continues his medical practice and research activities at his clinic and laboratory in Florida and is Chairman of the Board and Chief Scientific Officer of Phoenix Biosciences, Inc.

Robert H. Keller, MD, MS, FACP, AAHIVS

Education and Training: 
1966 Bachelor of Arts in Biology Master of Science in Biology Fordham University, Bronx, New York
1966 Bachelor of Arts in Biology Master of Science in Biology Fordham University, Bronx, New York
1970 Doctor of Medicine (MD) with honors Temple University, Philadelphia, Pennsylvania
1970-1974 Internship, Resident and Senior Resident University of Rochester, Rochester, New York
1974-1976 Fellow and Senior Fellow Department of Immunology Mayo Clinic, Rochester, Minnesota
1976 Master of Science in Immunology Mayo Graduate School of Medicine Rochester, Minnesota

Professional and Faculty Positions: 
2006 Founder, CSO and Director of Medicine KBK Institute of Advanced Medicine Hollywood, Florida
2001 Founder, Chairman, CEO & CSO Phoenix BioSciences which has developed a new first in class and first in man viral-host interaction inhibitor for HIV / AIDS
1999 Founder, Chairmain,CEO and CSO Vitimmune, Inc Hollywood, Florida
1998 Voluntary Adjunct Professor Miller School of Medicine, University of Miami Miami, Florida
1996 Chairman and CEO Immune Balance Technologies Hollywood, Florida
1994-2006 Director of Medicine & Research BIODORON Medical Center Hollywood, Florida
1994-1995 Consultant in Immunology and Hematology Health Professionals, Inc and Center for Special Immunology
1992-1995 Director Immune Reconstitution Program Center for Special Immunology
1992-1995 Medical Director Center for Special Immunology Miami Beach, Florida
1987-1996 President and Medical Director The Wilson Bode Center Fort Lauderdale, Florida
1986-1987 Associate Director of Research and Development Coulter Immunology Coulter Electronics, Inc., Hialeah, Florida
1982-1986 Medical Director Wilson Bode Center for Hematology and Immunology Research Milwaukee, Wisconsin
1982-1986 Clinical Professor Department of Health Sciences (Hematology, Immunology, Flow Cytometry) University of Wisconsin Milwaukee, Wisconsin
1982-1986 Associate Professor Departments of Medicine and Biophysics Medical College of Wisconsin Milwaukee, Wisconsin
1982-1986 Clinical Investigator and Staff Physician Zablocki VAMC Milwaukee, Wisconsin
1980-1982 Director of Immunology Midwest Children's Cancer Center (Immunology, Flow Cytometry, Transplantation) Chief of Immunology Milwaukee Children's Hospital Milwaukee, Wisconsin
1980-1982 Associate Professor Department of Pediatrics (Hematology/Oncology, Immunology) Medical College of Wisconsin Milwaukee, Wisconsin
1979-1982 Clinical Associate Professor Department of Health Sciences (Hematology, Immunology, Flow Cytometry) University of Wisconsin Milwaukee, Wisconsin
1978-1980 Research Associate and Staff Physician Research Service Zablocki VAMC Milwaukee, Wisconsin
1977-1980 Assistant Professor Department of Medicine (Hematology/Oncology) Medical College of Wisconsin Milwaukee, Wisconsin
1977 Consultant And Assistant Professor Department of Immunology Mayo Medical School Dept. of Medicine University of Minnesota
1974-1977 Fellow and Senior Research Fellow in Immunology Mayo Clinic Foundation Mayo Graduate School of Medicine Rochester, Minnesota

Hospital Staff Appointments: 
1976-1977 Mayo Clinic, Rochester, Minnesota
1977-1986 Zablocki VAMC, Milwaukee, Wisconsin
1977-1986 Milwaukee County Medical Complex, Milwaukee, Wisconsin
1992-1997 Mount Sinai Medical Center, Miami Beach, Florida
1992-1999 Cleveland Clinic Hospital, Fort Lauderdale, Florida
1992-1999 Miami Heart Institute, Miami Beach, Florida
1997-1999 Palmetto General Hospital, Hialeah, Florida
1997- 2005 South Shore Hospital, Miami Beach, Florida
1997- 2005 Memorial Medical Center, Hollywood, Florida
1992- Broward General Medical Center, Fort Lauderdale, Florida
1997- Hollywood Medical Center, Hollywood, Florida

Fellowships and Awards: 
1967-1969 Health Professions Scholarship
Temple University School of Medicine
1974-1975 Mayo Foundation Research Fellowship
Mayo Graduate School of Medicine
1975-1978 National Arthritis Foundation Fellowship
1978-1981 VA Career Development Award, Research Associate
1983-1986 VA Career Development Award, Clinical Investigator

Grant Support during Academic Tenure 
1978-1980 Alpha-fetoprotein Immunoregulation in a Model of Murine Lymphoma Veterans Administration Research Principal Investigator $210,000
1981-1986 Immunoregulatory Dysfunction in Non-Hodgkin's Lymphoma NIH, NCI Principal Investigator $430,000
1982-1986 Immunologic Studies of Environmental Lung Disease NIH (NIAID) Co-Principal Investigator $525,000
1983-1986 VA Career Development Award Clinical Investigator $240,000
1984-1986 Clinical Applications of Laser Flow Cytometry Principal Investigator NIH (RR Shared Equipment Program) $105,609
1984-1987 Immunoregulatory Dysfunction Principal Investigator VA $245,000
1985-1986 Monoclonal Antibodies in the Detection of Cervical Carcinoma Co-Principal Investigator Hillman Foundation $85,000
1986-1987 Isoprinosine Modulation of the Immuno- Regulatory Imbalances in AIDS and ARC Principal Investigator of FDA IND Newport Foundation $125,000
1986-1987 Isoprinosine Modulation of the Immuno- Regulatory Imbalances in AIDS and ARC Principal Investigator of FDA IND Newport Foundation $125,000

Honors: 
1970 Alpha Omega Alpha Temple University, School of Medicine
1970 Medical Degree with honors Temple University, School of Medicine
1979 Superior Performance Award in Research Veterans Administration
1980 Fellow, American College of Physicians
1991 Who's Who in Science and Technology
1994 Who's Who in the World
1996 Who's Who in Medicine and Science
1998 HIV Medical Professional of the Year PWAC, Broward County, Florida
1999 Humanitarian of the Year National Hemophilia Foundation
2001 2000 Outstanding Scientists of the 21st Century
2002 1000 Great Americans of the 21st Century
2003 America's Top Physicians in Internal Medicine, Immunology and Hematology
2004 Elected to Board of Governors

Academy of HIV Medicine of the State of Florida: 
2004 AMA Physicians Recognition Award
2005 Greatest Scholars of the Twenty First Century
2006 Health Professional of the Year Invited Lectureships:
1977 Second Fogarty International Conference on Neonatal Liver Disease Baltimore, Maryland
1977 International Conference on the Diagnosis and Prevention of Neural Tube Defects Los Angeles, California
1977 Second International Conference on Diagnostic Immunology Henniker, New Hampshire
1979 Radio immunochemical Detection of Cancer Albuquerque, New Mexico
1980 Visiting Professor of Hematology University of Mississippi Jackson, Mississippi
1981 Visiting Professor of Hematology University of California Irvine, California
1981 Third International Conference on Diagnostic Immunology, Section Chair
1982 Visiting Professor of Pathology University of Texas Medical Branch Galveston, Texas
1983 Visiting Professor of Medicine Wilfred Hall Air Force Research Center Galveston, Texas
1984 Visiting Professor Max Plank Institute for Biochemie Munich, Germany
2005 Visiting Professor of Immunology and Pharmacology Peking Union Medical School (University of Beijing) Beijing, China

Editorial Boards: 
1986-1990 Diagnostic Immunology
1984-1986 Journal of Leukocyte Biology
2005 Interventions in Aging

Reviewer: 
1990-Present Journal of Immunology
2005 Interventions in Aging

Consultant ships: 
Coulter Epics
Coulter Immunology
Corning Scientific
National Aeronautics and Space Administration (NASA)
Abbott HIV Advisory Board
Baxter Advisory Board for Hemophilia
Baxter Advisory Board for Hemophilia Inhibitor Patients
Consultant in Cancer Therapy, PRSS-J, Tokyo, 2005
Medical Advisory Council, American Federation of Hemophilia, 2002

Board of Director Appointments: 
2006 Member American Academy of HIV Medicine
2006 Member Biosource Therapeutics
2001 Chairman, Phoenix Bioscience
1999 Chairman, VitImmune
1996 Chairman, IBT

Scientific Advisory Boards: 
2006 Cytodyn Inc
2006 Acthelon Medical
2006 Bioscource Therapeutics

Certifications: 
National Board of Medical Examiners, 1971 and 1990
American Board of Internal Medicine, 1974
American Academy of HIV Medicine, 2001
American Academy of Anti Aging Medicine 2006

Current Medical Licensure: 
New York #112195
Wisconsin #19121
Florida #58991

Certification: 
ACLS 1990
ATLS 1990

Professional Societies: 
Alpha Omega Alpha
American Association for the Advancement of Science
American Association of Immunologists
American College of Physicians
American Federation of Clinical Research
American Society of Clinical Pathology
American Society of Hematology
International Society of Hematology
International Society of Hematopathology
International Immunocompromised Host Society
International Society of Analytical Cytology
Clinical Cytometry Society
New York Academy of Sciences
Clinical Immunology Society
National Organization for Rare Disorders
American Academy of Anti Aginig Medicine

Teaching Experience: 
1978-1980 Survey in Basic and Clinical Immunology Department of Medicine Medical College of Wisconsin
1980-1983 Principles of Laser Flow Cytometry Department of Health Sciences University of Wisconsin
1981 Special Topics in Immunology Immunoregulation in Cancer Department of Biology Marquette University
1983-1986 Co-Director Flow Cytometry Program University of Wisconsin Introduction to Flow Cytometric Analysis Principles of Image and Laser Cytometry Hybridomas and Monoclonal Antibodies Laboratory Evaluation of Immunoregulation Clinical Immunophenotyping and DNA Analysis Advanced Cytometry Advanced Cytometric Techniques

Invited Professional Lectures: 
1979 - Dr. Keller has been the invited speaker at more than 2500 state, regional, National, and international, medical and scientific seminars and workshops In the fields of:
AIDS and Immunoregulation
Clinical Immunology
Chronic Fatigue Syndrome and Fibromyalgia
Autoimmune Disease and Control of Aberrant Immune Response
Nutrition and the Immune Response
Hormones and the Immune Response
Hepatitis C
Hemophilia
Protecting the Immune System Before, During, and After Cancer Therapy.
Age Management

2000-2002 Host of Today's Health, WAXY 790 and Web streamed at Vitimmune.com and RobKellermd.org
2005-2006 Host of Voice America Web Based Interactive Radio Show, The Path to Wellness and Youth

Committee Service: 
1985-1986 Veterans Administration Development Research and Committee Clement J. Zablocki VAMC
1986-1989 VA Oncology Merit Review Board
1984-1986 International Society For Analytical Cytology: Research and Development
1983-1986 Controls & Standards University of Wisconsin: Co Chair Flow Cytometry
1983-1986 National Institutes of Health: Special Immunology Review Council Study Section
1980-1982 Medical College of Wisconsin Faculty Welfare Committee
1980-1982 Animal Care Committee
1982-1986 Flow Cytometry Protocol Committee
1992 Cancer Committee for Hollywood Medical Center
1998 Committee of Ten Thousand Medical Advisory Board
1996 National Hemophilia Federation: Medical Advisory Committee
1994 National Hemophilia Foundation- Florida Chapter Medical Advisory Committee
1994-1997 Mount Sinal Medical Center Cancer Committee
2001 Hollywood Medical Center Cancer Committee
2005 Underwriting Committee ProAssurance Malpractice
2005 AAHIVM Standards of Practice Committee

Statement of Research Interest: 

HIV: Dissection of the immune perturbations Associated with HIV infection including therapy with experimental immunomodulary agents.

Dissection of the immune perturbations Associated with hemophiliac complication and therapeutic intervention using experimental immunoregulatory agents.

Creation and utilization of unique `designer` monoclonal antibodies for the diagnosis, monitoring, imaging and therapy of human hematologic and solid tumor malignancies.

Immune response and immunoregulation: dissection of the basic human immune response and the roles of cytokines and other regulatory molecules and the demonstration and characterization of aberrant responses in neoplastic and immunologic disease.

Nutritional/ Hormonal Supplementation in Age Management and Immunologic Disease

Patents Issued:
R.H. Keller and Dr. X. Wen: Allerg-ease (Patent Number 6,180,106) (2000)
R.H. Keller, D.W. Kirchenbaum: ALL-Immune (Patent Number 6,262,019) (2002)
R.H. Keller, PBS 119 a novel treatment for chronic viral infections (Patent Number 6,734,192) (2004)

Patents Pending: 
Keller R.H. A novel treatment For Viral Infections (CIP) 2005
Keller RH: An improved method for glutathione production in mammals 2007
Keller RH: A nutritional formula to promote weight loss in mammals
Keller RH: A novel treatment for neurodegenerative diseases
Keller RH: A nutritional formula to improve short term memory function

Books: 
Keller, R.H. After Thirty, Some Maintenance Is Required-A Practical Guide to Age Management

Book Chapters:

Keller, R.H. and Tomasi, T.B.: Alpha-fetoprotein: A Potential Regulator of Immune Function. In Diseases of the Liver and Biliary Tract. Javitts, N.NIH, Bethesda, Maryland, pp. 119-134, 1977.

Keller, R.H., Calvinico, N.J., Fink, J.N., and Stevens, J.O.: Immunobiologic Aspects of Primate Hypersensitivity Pneumonitis. In Environmental Toxicology. Dungworth, D.L. (Ed), Academic Press, New York, pp.383-395, 1981.

Keller, R.H., Blake, D.G., Lyman, S. and Siebenlist, R.: The Immunobiology of Human Non-Hodgkin's' Lymphomas. In Clinical Cellular Immunology. Ludered, A. (ed). Humana Press, New York, pp. 213-246, 1982.

Patrick, C.W., Keller, R.H., and Horan, P.K.: Flow Cytometry, Cell Sorting and Hybridomas. American Society Clinical Pathology Press. St. Louis, MO, pp. 1-182, 1982.

Patrick, C.W., Parker, J., Keller, R.H., and Horan, P.K.: The Clinical Utility of Monoclonal Antibodies and Immunophenotyping. In Flow Cytometry and Cell Sorting in Hematologic Disease. American Society of American Pathologists Press. Chicago, IL pp. 1-191.

Calvinico, N.J., Fink, J.N., and Keller, R.H.: Hypersensitivity Pneumonitis. In The Immunology of the Lung. Bienenstock, J. (Ed), Academic Press, New York pp 365-366, 1984

Keller, R.H., Milson, T.J., Janicek, K.M., Patrick, L.C., Sohnle, P., and Patrick, C.W.: Clinical Utilization of the Technicon H-6000 Flow Cytochemical Flow System in Allergy Testing. In Proceedings of the 4th International Technicon Hematology Colloquium. Simson, E. (ed) Academic Press, New York, pp 179- 188, 1984.

Patrick, C.W., Horan, P.K, and Keller, R.H.: Immunophenotypic and Functional Analysis Using Laser Flow Cytometry: Clinical Utility. American Society of Clinical Pathology Press, Chicago, IL, 1985, pp. 1-168.

Patrick, C.W. and Keller, R.H.: Lymphocytes: Biochemistry, Physiology, Function and Morphology. In Principles of Hematology: Clinical and Laboratory Practice. R.L. Bick, (Ed) C.V. Mosby, St. Louis, MO in press.

Patrick, C.W. and Keller, R.H.: The Emerging Role of Laser Flow Cytometry and Monoclonal Antibodies in Clinical Medicine. In: Principles of Hematology: Clinical Laboratory Practice. R.L. Bick (Ed) C.V. Mosby, St. Louis, MO, in press.

Keller, R.H. and Patrick, C.W.: Characterization of the Human Myeloid Series by Monoclonal Antibodies. In Monoclonal Antibodies in Laboratory Medicine. Swartz, M. (Ed) Academic Press, New York, in press.

Patrick, C.W., McFadden, P.W., and Keller, R.H.: Immunophenotypic Analysis of Human Bone Marrow Employing Monoclonal Antibodies and Laser Flow Cytometry. In Proceedings of the Second International Conference on Technological Advances in Laboratory Hematology. Howen, B. (ed),Academic Press, 1985.

Keller, R.H., Janicek, K.M., and Patrick, C.W.: The Clinical Significance of Laser Flow Cytometry DNA Analysis. In Proceedings of the Second International Conference on Technological Advances in Laboratory Hematology. Howen, B. (Ed) Academic Press, New York, 1985.

Keller, R.H., Van Riel, F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G, Fletcher, M.A.: Association of Histocompatability Class II Antigens wit the Chronic Fatigue Immune Dysfunction Syndrome. In Clinical Infectious Disease. University of Chicago, Chicago, IL, 1994:18 (Supp 1): S154-6.

Antioxidants and the skin, A Paradigm for aging. Keller, R.H and E Arrayove (in press) 2004. glutathione in Aging and Immunologic Disease. Loss of Gastrointestinal During Aging and Immunologic Disease Both Ed R. Wallace and Mechanisms of Aging Dove Press N Z, 2006

Original Research Contributions and Invited Reviews: Keller, R.H. and Tomasi, T.B.: Alpha-fetoprotein, E-Rosette Formation and Tumor Cell Growth. N Engl J Med 293(24): 1265-1266, 1975.

Tomasi, T.B., Dattwyler, R., Murgita, R. and Keller, R.H.: Immunosuppression By Alpha-fetoprotein. Trans Am Assoc Phys. 88:293-298, 1976.

Geubel, A.P., Keller, R.H., Summerkill, W.H.J., Dickson, E.R., Tomasi, T.B. and Shorter, R.G.: Lymphocyte Cytotoxicity and Inhibition Studied with Autologous Liver Cells: Observation in Chronic Acute Liver Disease and the Primary Biliary Cirrhosis Syndrome. Gasterenterol. 71:450-459, 1976.

Keller, R.H. and Clavanico, N.J., and Tomasi, T.B.: Immunosuppressive Properties of AFP: Role of Estrogens. In Onco Developmental Gene Expression. Fichman, W.H. and Sell, S. (eds) Academic Press, New York, p.278, 1976.

Keller, R.H. and Tomasi, T.B.: Synthesis of Alpha-fetoprotein by Murine Lymphoid Cells in Allogenic Reactions. J Exp Med 143:1120, 1976.

Banks, P., Keller, R.H., Li, V.Y. and White, E.B.: Malignant Lymphomas of Plasmablastic Identity: A Neoplasm with Both "Immunoblastic" and Plasma Cell Features. Am J Med 64:609-610, 1978.

Keller, R.H., Atwater, J.S., Martin, R.S. and Tomasi, T.B.: Ataxia Telangiectasia, Immunosuppression and AFP: Is There a Relationship? In Prevention of Neural- Tube Defects. Crandall, B. (ed) Academic Press, New York, pp.27-40, 1978.

Guirgis, H.A., Lynch, H.T., Keller, R.H., Tomasi, T.B., Vandervoorde, J., Brodky, F., Lynch, J., Rankin, L. and Malony, K.: Carcinoembryonic Antigen (CEA) and Alpha-fetoprotein (AFP) in Cancer-Prone Families: Communicable Implications. In Proceeding of the Third Annual Symposium on the Detection and Prevention of Cancer. Part I (2), 1987.

Keller, R.H., Dattwyler, R.J., Harrison, E. and Tomasi, T.B.: Alpha-fetoprotein in Human Lymphoproliferative Disease. J Lab Clin Immunol, 2:93-98, 1979.

Kaplan, H.J., Meredith, T.A., Aeberg, T.M. and Keller, R.H.: Intraocular Reticulum Cell Sarcoma (Histiocytic Lymphoma) in Richter's Syndrome: A Neoplasm of the Immune System. Arch Opthal 98:707-710, 1980.

Keller, R.H., Blake, B.G., Lyman, S. and Siebenlist, R.: ImmunoregulatoryAbnormalities in Chronic Lymphocytic Leukemia. J Lab Clin Immunol 6:201-208, 1981.

Choi, H. and Keller, R.H.: Co-existence of Chronic Lymphocytic Leukemia and Hodgkin's Disease. Cancer 48:48-55, 1981.

Kaplan, H.J., Aeberg, T.M. and Keller, R.H.: Etiology of Recurrent Clinical Uveitis. Ber Dtsch Ophthal Ges 78:159, 1981.

Kaplan, H.J. and Keller, R.H.: Recurrent Clinical Uveitis: Cell Surface Markers on Vitreous Lymphocytes. Arch Ophthal 100:585-592, 1982

Keller, R.H., Fink, J.N., Lyman, S. and Pederson, G.: Suppressor Cells in Asymptomatic Pigeon Breeders. J Clin Immunol 2:46-51, 1982.

Milson, T.J., Grief, D. and Keller, R.H.: The Variable Effect of Cryopreservation on Peripheral Blood Mononuclear Populations. J Clin Lab Immunol 7:205-218, 1982.

Keller, R.H., Calvanico, N.J. and Stevens, J.O.: Hypersensitivity Pneumonitis In Non-human Primates. In Studies on the Relationship of Immunoregulation and Disease Activity. J Immunol 128:116-123, 1982.

Keller, R.H.: Alpha-fetoprotein: Biologic and Clinical Potential. In Tumor Imaging: The Radioimmunochemical Detection of Cancer. Burchiel, S. and Rhodes, B. (eds) Mason Publishing, New York, pp. 179-188, 1982.

Patrick, C.W. and Keller, R.H.: New Techniques in the Diagnosis of Hematopoietic Malignancies: Monoclonal Antibodies, Flow Cytometry and Cell Sorting. Am Soc Clin Pathol Sp Topic Series 20(3)106-109, 1982.

Keller, R.H., Libnoch, J.A., Patrick, C.W., Blake, D.G., Choi, H. and Hanson, R.D.: Fc Gamma Bearing T Cells in Non-Hodgkin's Lymphomas. Diag Immunol 1:27-32, 1983.

Keller, R.H., Feldman, E. and Libnoch, J.A.: Immunoregulatory Abnormalities the Kindred of Waldenstrum's Macroglobulinemia Patients. Am J Hematol 14:15-22, 1983.

Keller, R.H. and Calvanico, N.J.: Suppressor Macro-molecules. Crit Rev Immunol 5(2): 149-199, 1984.

Fudenberg, H.H., Wilson, G.B., Keller, R.H., Metcalf, J.F., Pauling, E.E., Stuart, E.J. and Floyd, E.: Clinical Application of the Leukocyte Migration Inhibition Assay: New Methods for Determining Transfer Factor Potency and for Prediction of Clinical Response. In Proceedings of the IV International Conference on Transfer Factor. Academic Press, New York, pp. 293-310, 1984.

Patrick, C.W. and Keller, R.H.: A Simple Device for the Collection of Cells Sorted by Flow Cytometry: Preservation of Integrity and Viability. Cytometry 5(3):308-311, 1984.

Keller, R.H., Milson, T.J., Janicek, K.M. and Patrick, C.W.: Monoclonal Antibodies: Clinical Utility and the Misunderstood Epitope. Lab Med 15(12):785-802, 1984.

Keller, R.H., Swartz, S.J., Leven, S., Bar Sella, S. and Fink, J.N.: Immunoregulation in Hypersensitivity Pneumonitis: Phenotypic and Functional Studies of Bronchoalveolar Lavage Lymphocytes. Am Rev Resp Dis 130:766- 771, 1984.

Patrick, C.W., Swartz, S.J., Harrison, K.A. and Keller, R.H.: Collection and Preparation of Hemopoietic Cells for Cell Marker Analysis. Lab Med 15(10): 659-665, 1984.

Patrick, C.W., Milson, T.J., McFadden, P.W. and Keller, R.H.: Flow Cytometry and Cell Sorting. Lab Med 15(11):740-745, 1984.

Wilson, G.B., Fudenberg, H.H. and Keller, R.H.: Guidelines for Immunotherapy of Antigen Specific Defects with Transfer Factor. J Clin Lab Immunol 13:51-58, 1984.

Baumann, M.A., Libnoch, J.A., Patrick, C.W., Choi, H. and Keller, R.H.: Prolonged Survival in Richter's Syndrome with Subsequent Re-emergence of Chronic Lymphocytic Leukemia: A Case Report Including Serial Cell Surface Phenotype Analysis. Am J Hematol 20:67-72, 1985.

Marti, G.E., Patrick, C.W., Muirhead, K., Magruder, L., Vail, M., Schuette, W., Keller, R.H., Horan, P.K. and Gralnick, H.R.: Normal Blood Density Gradient Lymphocyte Subset Analysis: In an Inter-Laboratory Flow Cytometric Comparison of 85 Normal Adults. Am J Hematol 20:41-52, 1985.

Milson, T.J., Patrick, C.W., Sohnle, P.G., Patrick, L.C. and Keller, R.H.: Flow Cytochemical Analysis of Atopic Reactions. Diag Immunol 3:182-186, 1986.

Milson, T.J., Patrick, C.W., Torke, N.J. and Keller, R.H.: Holding Media for Cell Surface Phenotyping Analysis, J Immunol Methods 87: 155-159, 186.

Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Immunoregulatory Abnormalities in Myelodysplastic Disorders. Am K Hematol 22:79-86, 1986

Hansen, R.M, Lerner, N., Abrams, R.A., Patrick, C.W., Malik, M.I. and Keller, R.H.: Chronic Lymphocytic Leukemia with Pure Red Cell Aplasia: Laboratory Demonstration of Persistent Leukemia in Spite of Apparent Complete Clinical Remission. Am J Hematol 22:79-86, 1986.

Baumann, M.A., Keller, McFadden, P.W., Libnoch, J.A and Patrick, C.W.: Myeloid Cell Surface Phenotype in Myelodysplasia: Evidence for Abnormal Persistence of an Early Myeloid Differentiation Antigen. Am J Hematol 23:22-26, 1986.

Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Correlation of Numbers of Natural Killer Cells with Clinical Course in Large Cell Lymphoma. Cancer 57:2309-2312, 1986.

Patrick, C.W., Ash, R., Libnoch, J.A. and Keller, R.H.: Clinical Cytometry and Immunophenotyping: I. Flow Cytometric Analysis of Normal Peripheral Blood and Bone Marrow. Path Immunopathol Res 6:64-76, 1987.

Patrick, C.W., Libnoch, J.A., Kallas, G.A. and Keller, R.H.: Sequential Immunophenotypic Studies in Chronic Lymphocytic Leukemia: UCLA Molecular Biology Symposium. Chronic Lymphocytic Leukemia: Recent Progress-Future Directions. R. Gale and K. Rai (eds) Alan R. Liss, New York, 59, 1987.

Keller, R.H., Libnoch, J.A., Kallas, G.A., and Patrick, C.W.: Sequential Evaluation of T Cell Subsets in B-CLL. UCLA Molecular Biology Symposium Chronic Lymphocytic Leukemia: Recent Progress-Future Directions. R. Galeand K. Rai (eds) Alan R. Liss, New York, 59, 1987.

Fudenberg, H.H, Whitten, H.D., Galbraith, G.M.P., Goust, J.M., Patrick, C.W. and Keller, R.H.: Deficiency of 'Interactive' T Cells in Individuals with Recurrent Infection: Effect of DLE-TF Therapy. Am J Med. In Press, 1994.

Keller, R.H., Van Reil, F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G. and Fletcher, M.A.: Association of Histocompatability Class II Antigens with the Chronic Fatigue Immune Dysfunction Syndrome. In Clin Inf Disease 1 8(Supp 1): S154-156, 1994.

Papers Submitted, In review and/or Revision 

Patrick, C.W. and Keller, R.H.: A Comparative Study of Anticoagulants in Cell Surface Maker Phenotyping and Functional Analysis. Am J Clin Pathol.

Keller, R.H., Choi, H., Libnoch, J.A. and Patrick, C.W.: A Natural Murine Model of Non-Hodgkin's Lymphoma. J Immunol (in revision).

Choi, H., Libnoch, J.A., Aimargo, U., Heckman, M. and Keller, R.H.: Castelman's Tumor: Well Differentiated Lymphocytic Lymphoma and Large Cell Lymphoma in a Single Patient. Human Pathol (in revision).

Keller R.H., Wen K., and Kirchenbaum G. ALL-ergese a TCM blend of standardized herbs for the treatment of allergies. (in revision)

Adult Growth Hormone Deficiency: A Correlate of Immune Overactivity (in preparation)

ABSTRACTS: Asterisks (*) denote those papers selected for presentation at national or international meetings.

* Keller, R.H., Dattwyler, R.J., Harrison, E. and Tomasi, T.B.: Alpha- fetoprotein in Human Lymphoproliferative Disease. Blood 46(4):1035, 1975.

* Guebel, A.P., Keller, R.H., Summerskill, W.H.J., Tomasi, T.B. and Shorter, R.G.: Cytotoxicity of Autologous and Normal Lymphocytes Against Isolated Liver Cells in Patients with Primary Biliary Cirrhosis. Gastroenterol 68:104, 1975.

* Keller, R.H., Summerskill, W.H.J., Guebel, A.P., Shorter, R.G., and Tomasi, T.B.: Alpha-fetoprotein and Suppression of Cell Mediated Immunity in Chronic Acute Liver Disease (CALD). Gastroenterol 70:A-43:901, 1976.

* Keller, R.H, Guirgis, H., Lynch, H. and Tomasi, T.B.: Alpha-fetoprotein (AFP) in Cancer Prone Families. Clin Res 24:331, 1976.

* Keller, R.H., Burritt, M.F., Thompson, R.L. and Tomasi, T.B.: Alpha- fetoprotein (AFP): Synthesis in Allogeneic Reactions. Clin Res 24:447, 1976.

* Keller, R.H., Burritt, M.F. and Tomasi, T.B.: Alpha-fetoprotein (AFP) Synthesis in Allogeneic Reactions. Eleventh Leukocyte Culture Conference, Tucson, AZ, September 1976.

* Guirgis, H.A., Lynch, H.T., Keller, R.H., Tomasi, T.B., Vandervoorde, J., Lynch, J., Rankin, L., Maoney, K. and Harris, R.: Carcinoembryonic Antigen (CEA) and Alpha-fetoprotein (AFP) in Cancer Prone Families. In Proceedings of the Scientific Session of the Third International Symposium on the Detection and Prevention, 1976.

* Vogten, A.J.M., Shorter, R.G., Summerskill, W.M.J., Keller, R.H. and Tomasi, T.B.: Cell Mediated Cytotoxicity Against Human Liver Lipoprotein in Liver Disease. Gastroenterol 71:A-41:934, 1976.

* Keller, R.H. and Tomasi, T.B.: AFP: A Potential Regulator of Immune Function. Second International Conference on Disease of the Liver. Bethesda, MA, March 1977.

Keller, R.H., Blake, D.G., Lyman, S., Libnoch, J.A. and Fabiance, M.: Suppressor Cells in Asymptomatic Chronic Lymphocytic Leukemia. Clin Res 27:298, 1979.

Keller, R.H., Blake, D.G., Lyman, S. and Siebenlist, R.: Altered Immunoregulation in Chronic Lymphocytic Leukemia. Blood 54:97A, 1979.

Blake, D.G., Libnoch, J.A., Lyman, S. and Keller, R.H.: Altered Immunologic Reactivity in Myelodysplastic Disorders. Blood, 54:97A, 1979.

* Miller, P.P, Jordan, R.E. and Keller, R.H.: Suppression of Human Lymphocyte Response by Circulating Immune Complexes. Clin Res 28: 351, 1980.

* Keller, R.H., Fink, N.J., Lyman, S. and Pederson, G.: Altered Immunoregulation in Hypersensitivity Pneumonitis. Clin Res 28:102, 1980.

* Keller, R.H., Lyman, S. and Siebenlist, R.: The Influence of Human Mononuclear Cell Histamine Production on T Cell Immunoregulation. Clin Res 28:230, 1980.

* Keller, R.H., Lyman, S. and Siebenlist, R.: Histamine in the Immune Response. 4th World Congress of Immunology, Paris, France. July 1980.

* Kaplan, H.J., Asberg, T.M. and Keller, R.H.: Lymphocyte Subset in Clinical Uveitis. Abs Assoc Res Vision Opthal p. 33, 1980.

* Siebenlist, R., Calvanico, N.J., Stevens, J.O. and Keller, R.H.: Immunoregulation in Hypersensitivity Pneumonitis. Fourth Midwest Autumn Immunology Conference, Chicago, IL, 1980.

* Lyman, S., Patrick, C.W. and Keller, R.H.: Non-Hodgkin's Lymphoma in the Mouse: A Naturally Occurring Murine Model of NHL. Fourth Midwest Autumn Immunology Conference, Chicago, IL, 1980.

* Young, D.G., Hussey, C.V., Keller, R.H. and Pisciotta, A.V.: Eradication of Acquired Factor VII Inhibitor in Hodgkin's Disease Following Chemotherapy. Am Fed Clin Res 28(4):731, 1980.

* Keller, R.H., Patrick, C.W., Swartz, S.J., Libnoch, J.A. and Jordan, R.E.: FlowCytometry as an Adjunct in the Diagnosis and Staging of Lymphoproliferative Disease. IX International Conference on Analytical Cytology. Schloss Elmau, Germany, 1980.

* Wilson, R.J., Greiff, D. and Keller, R.H.: Cryopreservation of Non- specific T Cell Suppressor Cells. Cryobiol 17:597, 1980.

* Pontzer, C. and Keller, R.H.: Rabbit Peripheral Blood T Cell Separation. Fed Am Soc Exp Biol, 1980.

* Keller, R.H., Calvanico, N.J. and Stevens, J.O.: Immunoregulation in Pigeon Breeders Disease. Clin Res 29:370, 1981.

* Keller, R.H., Kirchner, P., Lyman, S., Siebenlist, R., Choi, H. and Patrick, C.W.: Immunoregulatory T Cells in Non-Hodgkin's Lymphomas. Blood 58:313, 1981.

* Keller, R.H., Lyman, S., Choi, H. and Patrick, C.W.: A Natural Model of Non-Hodgkin's Lymphoma. Blood 58:524, 1981.

* Lauer, S., Casper, J., Keller, R.H., Kirchner, P. and Camitta, B.: The Use of Counterflow Centrifugation-Elutriation for the Separation of Bone Marrow Lymphoid Cells in Children with Acute Lymphocytic Leukemia (ALL) and Metastatic Solid Tumors. Blood 58:133, 1981.

* Keller, R.H., Choi, H. and Patrick, C.W.: Nodular Non-Hodgkin's Lymphoma in the Mouse. Blood 60:114A, 1982.

* Keller, R.H., Lyons, M., Troy, J. and Jordan, R.E.: Peripheral Blood Aneuploidy in Mycosis Fungoides and Pre-mycotic Lesions. Blood 60:146A, 1982.

* Keller, R.H., Swartz, S.J., Lyons, M., Troy, J. and Jordan, R.E.: Peripheral Blood Involvement in Skin-limited T Cell Malignancy. Am Fed Clin Res 31:568, 1983.

* Geoghegan, W.D., Jordan, R.E. and Keller, R.H.: Non-Langerhans Cells in the Keratinocyte Band in Culture Expressing HLA-DR. Invest Derm Am Fed Clin Res 31:568, 1983.

* Keller, R.H., Swartz, S.J., Patrick, C.W. and Kaplan, H.J.: Intraocular Lymphoma: A Possible Systemic Disease. Am Fed Clin Res 31:315, 1983.

* Patrick, C.W., Libnoch, J.A., Choi, H. and Keller, R.H.: Flow Cytometric Peripheral Blood Cell Surface Analysis as a Predictor of Richter's Syndrome (RS) in Chronic Lymphocytic Leukemia. Blood 62:756, 1983.

* Patrick, C.W., Swartz, S.J. and Keller, R.H.: A Comparative Study of Heparin and Potassium EDTA as Anticoagulants for Cell Surface Marker and Immunologic Functional Analysis. Am J Clin Pathol, 1983.

* Keller, R.H., Swartz, S.J., Patrick, C.W., Steven, G. and Torke, N.J.: Regression of Natural Murine Non-Hodgkin's Lymphoma Following Immunotherapy with Immunoregulatory Cell Types. Blood 62:756, 1983.

* Keller, R.H., Wagner, D. and Patrick, C.W.: Sequential T Cell Phenotypic and Functional Changes During a Comparative Study of Rhinovirus Infection in Patients with the Acquired Immune Deficiency Syndrome (AIDS). Blood 62:352, 1983.

* Keller, R.H., Swartz, S.J. and Patrick, C.W.: Metachromatic Granules in Human T8 (CD8) Bearing Lymphocytes. Fifth World Congress of Immunology. Tokyo, Japan. July 1983.

Libnoch, J.A., Patrick, C.W., Griffin, J. and Keller, R.H.: Flow Cytometric Cell Surface Analysis as a Predictor of Leukemic Transformation in the Myeo-dyplastic Syndrome (MDS). Blood 62:610A, 1983.

* Calvanico, N.J., Pontzer, C. and Keller, R.H.: Regulation of Aerosol Induced Pulmonary Inflammation in Rabbits. XII Congress of the European Academy of Allergy and Clinical Immunology, Rome, Italy, 1983.

* Patrick, C.W., Swartz, S.J., McFadden, P.W., Wallace, A. and Keller, R.H.: A Comparative Study of Manual and Flow Cytometry Cell Surface Marker Analysis. Soc Analytical Cytology, Sea Island, Georgia, 1983.

* Keller, R.H., Swartz, S.J., Troy, J., Patrick, C.W. and Jordan, R.E.: Peripheral Blood Involvement in Skin Limited T Cell Malignancy. Soc Analytical Cytology, Sea Island, Georgia, 1983.

* Keller, R.H., Swartz, S.J., Leven, S. and Bar Sella, S.: Immunoregulation in Hypersensitivity Pneumonitis: Phenotypic and Functional Studies of Bronchoalveolar Lavage Lymphocytes. Am Acd Allergy 130:766-771, \ 1984.

* Keller, R.H., Swartz, S.J., McFadden, P.W., Milson, T.J., Hermann, J., Thomas, E. and Patrick, C.W.: Abnormal Peripheral Blood T Cell DNA Content in Skin Limited T Cell Malignancy. Second International Conference on Malignant Lymphoma, Lugano, Switzerland, June 1984.

* Patrick, C.W., Harrison, K.A, Libnoch, J.A., Cozine, M.G. and Keller, R.H.: Monoclonal Antibody Profiles in Human B Cell Lymphoproliferative Disorders Suggests that B4 Positive Lymphocytes which Lack Expression of B1 Antigen May Include the B Memory Cells. Second International Conference on Malignant Lymphoma, Lugano, Switzerland, June 1984.

* Patrick, C.W., McFadden, P.W., Buchholz, T.B., Milson, T.J., Libnoch, J.A. and Keller, R.H.: The Non-relevance of T4 to T8 (CD4:CD8) Ratios to Disease Activity in B Cell Malignancies. Second International Conference on Malignant Lymphoma, Lugano, Switzerland, June 1984.

* Keller, R.H., Swartz, S.J., Patrick, C.W., Steven, G. and Torke, N.J.: Treatment of Naturally Occurring Murine Non-Hodgkin's Lymphomas Using Immunoregulatory Cell Types and IL-2. Second International Conference Malignant Lymphoma, Lugano, Switzerland, June 1984.

* Kissebah, A.H., James, R. Krakower, G., Arnaud, C., Etienne, J. and Keller, R.H.: Holding Media for Cell Surface Phenotypic Analysis. Midwest Autumn Conference, Chicago, IL, November 1984.

* Milson, T.J., Patrick, C.W., Torke, N.J., Janicek, K.M., Harrison, K.A. and Keller, R.H.: Alterations in Lymphoid and Myeloid Cell Surface Marker Phenotype Profiles Associated with the Development of Basophilic Crisis in Chronic Granulocytic Leukemia (Ph + CGL). Blood 64(5):195A, 1984

* Patrick, C.W., Libnoch, J.A., Milson, T.J., Kortright, K.H. and Keller, R.H.: Common Variant of B Cell Chronic Lymphocytic Leukemia is Defined by the Monoclonal Antibody TQ1 (Leu 8). Blood 65(5):149, 1984.

* Baumann, M.A., Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Myeloid and Lymphoid Cell Surface Phenotype in Myelodysplasia: Correlation with In Vitro Assessment of Immune Function. Blood 64(5):186A, 1984.

* Keller, R.H., Larrick, J.W., Swartz, S.J., Torke, N.J. and Patrick, C.W.: Treatment of a Natural Model of Murine Non-Hodgkin's Lymphoma with Recombination Interleukin 2(IL-2). Blood 64(5):181, 1984.

* Steven, G.C., Choi, H., Heckman, M.G. and Keller, R.H.: Comparison of Flow Cytometry and In sit Cell Surface Marker Analysis. Midwest Student Research Forum XVI, Wright State University, February 1985.

* Kissebah, A.H., Krakower, G., James, R., Aranaud, C., Etienne, J. and Keller, R.H.: Regional Differences in Preadiopocyte Growth Potential from Immature and Sexually Mature Female Rats. Am Fed Clin Res 33:434, 1985.

* Kissebah, A.H., Krakower, G., James, R., Aranaud, C., Etienne, J. and Keller, R.H.: Regional Specialization of Subcutaneous Tissue Growth Potential: Relationship to Ovarian Function. Am Diabetes Assoc, Toronto, Canada, November 1985.

* Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Correlation of Natural Killer Cell Count with Prognosis in Large Cell Lymphoma. Blood 66:185, 1985.

* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Clinical Utility of Dual Immunofluorescence Assay of Monoclonal Antibodies TQ1 and (CD19) on Peripheral Blood Cells in Chronic Lymphocytic Leukemia. Blood 66: 181, 1985.

* Patrick, C.W., Libnoch, J.A., Baumann, M.A. and Keller, R.H.: Alterations of Myeloid Surface Receptors recognized by the Monoclonal Antibody MY 9 (CD33) in the Peripheral Blood May Serve to Identify Those Myelodysplastic Patients at Increased Risk for Leukemic Conversion. Blood 66:226, 1985.

Keller, R.H., Milson, T.J., McFadden, P.W. and Patrick, C.W.: In Vitro Augmentation of Immunologic Responsiveness in Patients with AIDS and ARC Using Isoprinosine. Blood 66:113, 1985.

Keller, R.H., Patrick, L.C. and Patrick, C.W.: Isoprinosine Augments In \ Vitro Immunoglobulin Synthesis in Chronic Lymphocytic Leukemia. Blood 66:202, 1985.

* Keller, R.H., Patrick, L.C. and Patrick, C.W.: Isoprinosine Augments In Vitro Immunoglobulin Synthesis in Chronic Lymphocytic Leukemia (B-CLL). International Symposium on Recent Approaches to Chronic Lymphoproliferative Disease, Prague, Czechoslovakia, September 1985.

* Keller, R.H., Milson, T.J. and Patrick, C.W.: The Relationship of Larger Lymphoid Elements, Clonally Restricted DNA Cell Cycle Analysis and Rai Staging in Chronic Lymphocytic Leukemia (B-CLL). International Symposium on Recent Approaches to Chronic Lymphoproliferative Disease, Prague, Czechoslovakia, September 1985.

* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Immunophenotypic Dissection Of Chronic Lymphocytic Leukemia. International Symposium on Recent Approaches to Chronic Lymphoproliferative Disease, Prague, Czechoslovakia, September 1985.

* Keller, R.H., Libnoch, J.A., Patrick, L.C. and Patrick, C.W.: In Vitro Improvement of Cellular and Humoral Immune Response by Isoprinosine in B-CLL. XXI Congress of the International Society of Haematology, Sydney, Australia, May 1986.

* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Prolymphocytic Leukemia of B Cells is a Distinct Biologic Stage in B Cell Maturation. XXI Congress of The International Society of Haematology, Sydney, Australia, May 1986.

* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Sequential Changes in the Expression of Lymphoid Surface Membrane Receptors in Chronic B Cell Lymphoproliferative Disease. XXI Congress of the International Society of Haematology, Sydney, Australia, May 1986.

* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Clinical Utility of Dual Immunofluorescence Assay of Monoclonal Antibodies TQ1 and B4 (CD19) on Circulating B Cells in Chronic Lymphocytic Leukemia (B-CLL). Sixth International Congress of Immunology, Toronto, Canada, July 1986.

* Keller, R.H., Milson, T.J., Ellingboe, K.M. and Patrick, C.W.: Sequential Clinical, Immunoregulatory, Phenotypic and Functional Changes in Patients with AIDS and ARC treated with Isoprinosine. XXI Congress of the International Society of Haematology, Sydney, Australia, May 1986.

* Keller, R.H., Milson, T.J., Ellingboe, K.M. and Patrick, C.W.: Sequential Clinical, Immunoregulatory, Phenotypic and Functional Changes in Patients with AIDS and ARC treated with Isoprinosine. International Conference on the Acquired Immunodeficiency Syndrome, Paris, France, June 1986.

* Keller, R.H., Libnoch, J.A. and Patrick, C.W.: T Cell Alterations in B-CLL: Sequential Changes in CD4 and CD8 Bearing Cells and in T Cell Immunoregulation. UCLA Symposium on Molecular and Cell Biology, Silverado, California, December 1986.

* Patrick, C.W., Libnoch, J.A., Kallas, G.A. and Keller, R.H.: Sequential Immunophenotypic Studies in Chronic Lymphocytic Leukemia. UCLA Symposium on Molecular and Cell Biology, Silverado, California, December 1986.

* Reiter, W.M., Berger, D.S., Vorce, S., Cimoch, P.J., Vargas, A. and Keller, R.H.: Combination Zidovudine and Didanosine Therapy for Patients Remaining Persistently HIV P24 Antigen-Positive Despite Zidovudine Monotherapy. VIII International AIDS Conference, Amsterdam, Netherlands, 1992.

* Reiter, W.M., Keller, R.H., Cimoch, P.J. and Forgione, A.: A Rapid Quantitative Flow Cytometry Assay to Evaluate CD4 + - Lymphocyte Activation Potential in Patients with HIV-1 Infection. VIII International AIDS Conference, Amsterdam, Netherlands, 1992.

* Cimoch, P.J., Reiter, W.M., Vorce, D., Cassarella, S.K., Thompson, B. and Keller, R.H.: The Occurrence of Cytomegalovirus (CMV) Viruria in Late- Stage HIV-1 Infection and its Association with CMV Organ Involvement. VIII International AIDS Conference, Amsterdam, Netherlands, 1992.

* Reiter, W.M., Beach, R.S., Vorce, D., Cimoch, P.J., Vargas, A., Thompson, B. and Keller, R.H.: Longitudinal Analysis the Effect of Anti-retroviral Monotherapy on CD4+ Lymphocyte Percentage. VIII International AIDS Conference, Amsterdam, Netherlands, 1992.

* Keller, R.H., Van Reil, F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G. and Fletcher, M.A.: Correlation of DR4 and DQ1 with Immunologic Defects in the Chronic Fatigue Syndrome. First International Chronic Fatigue Syndrome Research Conference, Albany, New York, October 1992.

* Keller, R.H., Reiter, W.M., Lane, J.T., Klimas, N.G., Vargas, A. and Maislis, J.A.: Treatment of Late-Stage AIDS Patients with Combined Monthly Anti-HIV Hyperimmunoglobulins and Haplotype-matched Peripheral Blood Lymphocytes. XI International Conference on AIDS, Berlin, 1993.

Reiter, W.M., Cimoch, P.J., Vorce, D.E., Keller, R.H., Berger, D. and Ping, A.:Eighteen Month Longitudinal Analysis of the Effect of Zidovine MonotherapyCompared to Combination Antiretroviral Therapy on HIV1 Disease Progression. IX International Conference on AIDS, Berlin 1993.

* Reiter, W.M., Vorce, D.E., Cimoch, P.J., Keller, R.H., Berger, D.S., and Ping, A.C.: Cytotoxic CD8+ Lymphocyte Response to HIV-1 Infection Correlated with Longitudinal Analysis of CD4+ Lymphocyte Percentage. IX International Conference on AIDS, Berlin, 1993

Berger, D.S., Reiter, W.M., Vorce, D.E., Cimoch, P.J., Keller, R.H. and Ping, A.C.: Prevalence of Red Blood Cell Magnesium Deficiency in HIV-1 Infected Patients and its Association with Fatigue and Myalgia. IX International Conference on AIDS, Berlin, 1993.

Reiter, W.M., Tomaka, F., Keller, R.H., Cimoch, P.J., Vargas, A. and Vorce, D.E.: Unrecognized Moderate to Advanced Immunodeficiency in "HIV-Aware" Asymptomatic, Untreated Person with HIV-1 Infection. IX International Conference on AIDS, Berlin, 1993.

* Gomatos, P.J., Keller, R.H., Reiter, W.M., Lane, J.T., Cimoch, P.J., Vorce, D.E., Gianetti, B.L. and Uribe, M.R.: Haplotype-Matched Peripheral Blood Mononuclear Cell (PBMC) Transfusions in Patients with Late-Stage AIDS. X International Conference on AIDS, Yokohama, Japan, 1994.

* Cimoch, P.J., Loss, S.D., Houghton, R.A., Reiter, W.M., Keller, R.H., Vorce, D.E., Nemecheck, P.M., Berger, D.S. and Tomaka, F.L.: Antibody Response to Pneumococcal Vaccination in HIV-1 Infected Patients. X International Conference on AIDS, Yokohama, Japan, 1994.

* Tomaka, F.L., Cimoch, P.J., Reiter, W.M., Keller, R.H., Berger, D.S., Piperato, J.R., Nemecheck, P.M., Loss, S.D. and Houghton, R.A.: Prevalence of Nutritional Deficiencies in Patients with HIV-1 Infection. X International Conference on AIDS, Yokohama, Japan, 1994.

* Keller, R.H., Helder, L.M., Piperato, J.P., Klimas, N.G., Reiter, W.M., Fletcher, M.A., Vorce, D.E. and Pittibone, H.: Symptomatic Improvement Associated with Down Regulation of Immune Hyper Reactivity by Calcium Channel Blockade in CFIDs. American Association for Chronic Fatigue Syndrome Research Conference, Ft Lauderdale, Florida, 1994.

* Keller, R.H., Nolan, R.P. and Patrick, L.C.: Natural Human Interferon ( (Alpha Leukoferon) Therapy in a Cohort of Hemophiliacs Co-infected with . HIV and Hepatitis C. Fourth Conference on Retroviruses and Opportunistic Infections,Washington, DC, 1997.

* Patrick, C.W. and Keller, R.H.: Patient Screening for Myelodysplasia in Long- Term HIV+ Individuals. Conference on Clinical Laboratory Testing in HIV, Atlanta, GA, 1998.

* Patrick, C.W., DeLeon, M., A. Leon, and Keller, R.H.: Measurement of glutathione (GSH) as Indicator of Immune Status. Conference on Clinical Laboratory Testing in HIV, Atlanta, GA 1998.

** Kushch, A. and Keller, R.H.: Neuropsychological Correlates of Adjunct Therapy with a Nutritional/Vitamin Supplement in a Medical Patient Sample. National Academy of Neuropsychology, ** Orlando, FL, November 2000.

Keller, R.H.:PBS 119 Abstract "Clinical Results of PBS 119 in Eight Patients for Two Years" Submitted to the 12th Conference on Retroviruses & Opportunistic Infections (CROI), 2005

Keller, R.H.: PBS 119 Abstract "In Vitro Analysis of PBS 119 Against HIV Viral Activity in Lab Adapted and HAART Resistant Strains of HIV" Submitted to the 12th Conference on Retroviruses & Opportunistic Infections (CROI), 2005

* Keller, R.H, Miller D glutathione and DHA deficiency in HIV/AIDS : Correction with Immune Vitality 16th International AIDS congress Toronto Canada 8/2006

* Keller, R.H And Nyugen V. : PBS 119 A Novel Host - Viral Interaction inhibitor 16th International AIDS Congress Toronto Canada 8/2006

Dr. Keller has served on the faculties of the Mayo Graduate School of Medicine, the University of Wisconsin and the Medical College of Wisconsin (Marquette Univ.) He has published more than 100 original articles in various scientific and medical journals and has been awarded several patents. Dr Keller was elected to The Board of Governors of the American Academy of HIV medicine, and serves on the Scientific Advisory Board of several Biotech companies. The Consumers’ Research Council has named Dr. Keller one of America’s “Top Physicians in 2003, 2004 and 2005 in the fields of Internal Medicine, Immunology and Hematology. Dr. Keller continues his medical practice and research activities at his clinic and laboratory in Florida and is Chairman of the Board and Chief Scientific Officer of Phoenix Biosciences, Inc.

To buy as a Preferred Customer if you are from Australia,

 Cameroon, Canada, Colombia, Costa Rica, Dominican Republic,

 Ecuador, El Salvador, Fiji, Ghana, Guatemala, HongKong, 

Ivory Coast, Kenya, Malaysia, Mexico, New Zealand, Nigeria,

 Philippines, Singapore and United States... 

please click on BUY NOW below